Data Foundry

Drug recalls 2025

TESTOSTERONE PELLET 200 mg BLUNT — Class II drug recall D-0416-2025

Ongoing recall by BSO LLC, reported 2025-05-14, distributed nationwide. Presence of Particulate Matter: Glass particles were found in pellet vials.

Recall numberD-0416-2025
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmBSO LLC, Lakewood, CO, United States
Recall initiated2025-04-28
Classified2025-05-06
Reported by FDA2025-05-14
DistributedNationwide (US)
Quantity1,964 vials
Reason classesforeign material, specification failure
NDC70168-0121-01
Expiration dates2026-01-17, 2026-01-25

Product

TESTOSTERONE PELLET 200 mg BLUNT, 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0121-01

Reason for recall

Presence of Particulate Matter: Glass particles were found in pellet vials.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0416-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.